Clinical trials: Syncope, Vasovagal, Neurally-Mediated

Syncope

ISSUE3: International Study on Syncope of Uncertain Etiology 3

• Completed
• Age: 40 years and older
• Phase 4
• Medical device
• Results posted

ISSUE 3 is a multi-center, prospective, randomised controlled double-blind study aimed to assess the effectiveness of pacemaker therapy for prevention of asystolic neurally-mediated syncope.

Trial name

NCT00359203

Testing

Dual chamber pacemeker

Where

Italy

Volunteers

511 people

Sponsor

Medtronic Cardiac Rhythm and Heart Failure